Pfizer
Trade Pfizer 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About PFE
Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases.
PFE Key Statistics
PFE News
Key Insights Pfizer's Annual General Meeting to take place on 24th of April CEO Albert Bourla's total compensation includes salary of US$1.80m The overall pa...
Pharmaceutical products imported to the US in the first January and February reached $37 billion, compared to $31 billion during the same period last year. Pha...
Novavax (NVAX) announced preliminary results from the SHIELD-Utah study that showed Novavax’s COVID-19 Vaccine, Adjuvanted 2024-2025 Formula targeting the JN.1...
Analyst ratings
61%
of 23 ratingsMore PFE News
The stock of U.S. pharmaceutical giant Eli Lilly (LLY) is up 3% on news that rival Pfizer (PFE) has ended development of its experimental weight loss pill. The...
recently announced the cessation of Danuglipron's development, an event that coincided with a 3% decline in its share price over the past week. This move was pr...
BTIG highlights “some of the most compelling reasons” to own Viking Therapeutics (VKTX) after news from Pfizer (PFE) on the latter’s discontinuation of danuglip...
Viking Therapeutics, Inc. VKTX, Eli Lilly And Co LLY and Novo Nordisk A/S NVO stocks are trading higher on Monday. Pfizer Inc. PFE announced on Monday that it...
Pfizer (PFE) announced Monday that it is ending development of its daily weight-loss pill following a liver injury to a patient participating in a trial. The p...
Shares of Viking Therapeutics (VKTX) and Structure Therapeutics (GPCR) are on the rise on Monday after Pfizer (PFE) announced its decision to discontinue develo...
Pfizer Inc. PFE is discontinuing development of an oral glucagon-like peptide-1 (GLP-1) receptor agonist being investigated for chronic weight management. Pfiz...
